Canadian General Medical Center Complex Company (9518.SR) — Financial statements
Income statement, balance sheet, and cash flow for Canadian General Medical Center Complex Company — annual and quarterly history with growth and margin analysis.
| Metric (SAR Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 111↑10.4% | 100↑23.5% | 81↑15.0% | 71↑10.0% | 64 | |
| Cost of Revenue | 82↑19.7% | 69↑22.3% | 56↑23.8% | 45↑13.1% | 40 | |
| Gross Profit | 27↓14.3% | 32↑26.3% | 25↓0.9% | 25↑4.9% | 24 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 4↑141.7% | 2↑2.0% | 2↓38.1% | 3↑97.8% | 1 | |
| Selling & Marketing Expenses | 0.45↓45.9% | 0.84 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 5↑81.3% | 3↑50.4% | 2↓38.1% | 3↑97.8% | 1 | |
| Other Expenses | 12↓7.5% | 13↑118.0% | 6↓1.9% | 6↑11.8% | 5 | |
| Operating Expenses | 17↑7.3% | 16↑102.8% | 8↓13.2% | 9↑29.5% | 7 | |
| Total Costs & Expenses | -99↓217.4% | 84↑32.0% | 64↑17.7% | 54↑15.5% | 47 | |
| Operating Results | ||||||
| Operating Income | 12↓26.6% | 16↓7.9% | 17↑5.9% | 16↓5.0% | 17 | |
| Depreciation & Amortization | 4↑132.3% | 2↓44.8% | 3↑7.0% | 3↑3.8% | 3 | |
| EBITDA | 17↓12.5% | 20↓8.1% | 22↑9.0% | 20↓1.5% | 20 | |
| EBIT | 13↓26.3% | 18↓1.9% | 19↑9.1% | 17↓1.6% | 17 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↑300.8% | -0.66↓261.8% | 0.41↑197.3% | -0.42↑34.6% | -0.64 | |
| Interest Income | 2 | 0.00↓100.0% | 0.97 | 0.00 | 0.00 | |
| Interest Expense | 0.51↓22.6% | 0.66↑16.8% | 0.56↑34.8% | 0.42↓34.6% | 0.64 | |
| Non-Operating Income | -2↑24.1% | -2↓79.4% | -1↓84.7% | -0.69↓550.1% | -0.11 | |
| Other Income / Expenses | 1↓37.5% | 2↑175.1% | 0.71↑213.7% | 0.23↑150.6% | -0.45 | |
| Income Before Tax | 13↓27.8% | 18↓0.6% | 18↑8.7% | 17↓1.1% | 17 | |
| Income Tax Expense | 3↑22.0% | 2↓7.2% | 2↓6.0% | 2↑341.6% | 0.56 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 10↓34.6% | 16↑0.4% | 16↑11.3% | 14↓12.9% | 16 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 10↓34.6% | 16↑0.4% | 16↑11.3% | 14↓12.9% | 16 | |
| Bottom-Line Net Income | 10↓34.6% | 16↑0.4% | 16↑11.3% | 14↓12.9% | 16 | |
| EPS (Basic) | 0.13↓35.0% | 0.20↑0.0% | 0.20↑11.1% | 0.18↓14.3% | 0.21 | |
| EPS (Diluted) | 0.13↓35.0% | 0.20↑0.0% | 0.20↑11.1% | 0.18↓14.3% | 0.21 | |
| Weighted Average Shares | 77↑0.0% | 77↑0.0% | 77↑0.0% | 77↑0.0% | 77 | |
| Weighted Average Diluted Shares | 77↑0.0% | 77↑0.0% | 77↑0.0% | 77↑0.0% | 77 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.